| Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-γ and IL-12 CS Garris, SP Arlauckas, RH Kohler, MP Trefny, S Garren, C Piot, ... Immunity 49 (6), 1148-1161. e7, 2018 | 907 | 2018 |
| A neutrophil response linked to tumor control in immunotherapy J Gungabeesoon, NA Gort-Freitas, M Kiss, E Bolli, M Messemaker, ... Cell 186 (7), 1448-1464. e20, 2023 | 192 | 2023 |
| Tumor-promoting Ly-6G+ SiglecFhigh cells are mature and long-lived neutrophils C Pfirschke, C Engblom, J Gungabeesoon, Y Lin, S Rickelt, R Zilionis, ... Cell reports 32 (12), 2020 | 100 | 2020 |
| Single extracellular vesicle protein analysis using immuno‐droplet digital polymerase chain reaction amplification J Ko, Y Wang, JCT Carlson, A Marquard, J Gungabeesoon, A Charest, ... Advanced biosystems 4 (12), 1900307, 2020 | 69 | 2020 |
| Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy M Siwicki, NA Gort-Freitas, M Messemaker, R Bill, J Gungabeesoon, ... Science immunology 6 (61), eabi7083, 2021 | 63 | 2021 |
| Macrophage-targeted therapy unlocks antitumoral cross-talk between IFNγ-secreting lymphocytes and IL12-producing dendritic cells C Pfirschke, R Zilionis, C Engblom, M Messemaker, AE Zou, S Rickelt, ... Cancer immunology research 10 (1), 40-55, 2022 | 34 | 2022 |
| Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-γ and IL-12 CS Garris, SP Arlauckas, RH Kohler, MP Trefny, S Garren, C Piot, ... Immunity 55 (9), 1749, 2022 | 23 | 2022 |
| Loss of T-cell protein tyrosine phosphatase in the intestinal epithelium promotes local inflammation by increasing colonic stem cell proliferation S Bussières-Marmen, V Vinette, J Gungabeesoon, I Aubry, ... Cellular & Molecular Immunology 15 (4), 367-376, 2018 | 20 | 2018 |
| Localizing PRL-2 expression and determining the effects of dietary Mg2+ on expression levels J Gungabeesoon, ML Tremblay, N Uetani Histochemistry and cell biology 146, 99-111, 2016 | 19 | 2016 |
| Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-gamma and IL-12 (vol 49, 1148. e1, 2018) CS Garris, SP Arlauckas, RH Kohler, MP Trefny, S Garren, C Piot, ... Immunity 55 (9), 1749-1749, 2022 | | 2022 |
| Neutrophil heterogeneity in cancer J Gungabeesoon Harvard University, 2022 | | 2022 |